AwardedSpainGoods
Suministro de tremelimumab (imjudo®) y tezepelumab (tezspire®) de distribución exclusiva del laboratorio Astrazeneca farmacéutica Spain, S.A. con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid
- Published
- Published 11 March 2026
Overview
Suministro de tremelimumab (imjudo®) y tezepelumab (tezspire®) de distribución exclusiva del laboratorio Astrazeneca farmacéutica Spain, S.A. con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 11 March 2026
Pharmaceutical products
Award outcome
- Awarded value
- €369,467
- Award date
- 28 February 2026
- ASTRAZENECA FARMACAUTICA SPAIN, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
11 March 2026
Contracting authority
HOSPITAL CLINICO SAN CARLOS DE MADRID
Procuring entityMADRID, Spain
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.